Quick Order Cart

Cat. No. ARG34209

GTF2H5 Knockout jurkat Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Blood (peripheral blood)

  • Disease:

    Acute lymphoblastic leukemia (ALL)

CRISPR/Cas9-edited polyclonal knockout cell population of Jurkat T lymphocytes engineered to disrupt the GTF2H5 gene. GTF2H5 encodes a critical stabilizing subunit of the TFIIH complex, which coordinates RNA polymerase II transcription initiation and nucleotide excision repair (NER). This loss-of-function model enables the study of transcription-coupled repair, DNA damage responses, and diseases such as trichothiodystrophy and photosensitivity disorders. The Jurkat background provides well-characterized T-cell receptor signaling and apoptosis pathways, while GTF2H5 knockout disrupts interactions with TFIIH subunits such as XPB, XPD, and CDK7. Applications include UV sensitivity and comet assays, transcriptional profiling, apoptosis quantification, and screening of NER-targeted therapies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Jurkat

    Cell Type

    T cell line

    Sex of Donor

    Male

    Age

    14 years

    Derived From Site

    In situ; Peripheral blood

    Gene Name

    GTF2H5

    Gene Identifier

    NCBI Gene ID 404672

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GTF2H5 knockout Jurkat polyclonal cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from Jurkat human T lymphocytes, providing a loss-of-function model for the GTF2H5 gene. GTF2H5 encodes a critical subunit of the transcription factor IIH (TFIIH) complex, essential for RNA polymerase II transcription initiation and nucleotide excision repair (NER). This polyclonal pool, created via CRISPR/Cas9-mediated gene disruption, yields heterogeneous edits that avoid clonal artifacts and capture population-level variation, enabling robust assessment of GTF2H5 function in a well-characterized T-cell background.

The Jurkat cell line, derived from acute T-cell leukemia, is an immortalized human T lymphocyte widely used to model T-cell receptor signaling, apoptosis, and immune function. Its extensive characterization and genetic tractability make it ideal for studying gene function in lymphoid cells, with well-defined signaling and apoptotic pathways that facilitate examination of DNA repair and cell survival crosstalk.

GTF2H5 (p8/TTD-A) is an integral TFIIH subunit that stabilizes the core complex composed of XPB, XPD, p62, p52, p44, and p34. It directly interacts with Cdk7, Cyclin H, and MAT1 to modulate kinase activity for RNA polymerase II recruitment and phosphorylation during transcription initiation. In NER, GTF2H5-anchored TFIIH unwinds damaged DNA, enabling lesion recognition and incision by factors like XPA, XPC, XPF-ERCC1, and XPG. Consequently, GTF2H5 functions upstream of RNA polymerase II-dependent gene transcription and downstream of TFIIH assembly factors, connecting it to cell cycle control and genome integrity.

In Jurkat T cells, GTF2H5 knockout destabilizes TFIIH, causing severe defects in transcription-coupled repair and global transcription, with heightened UV sensitivity and apoptosis. This mirrors trichothiodystrophy and photosensitivity disorders, where GTF2H5 mutations impair NER without full cancer proneness. The Jurkat model further permits investigation of how compromised transcription and repair impact T-cell activation, proliferation, and immune functions.

Applications span transcription-coupled repair analysis, trichothiodystrophy modeling, and DNA damage response studies, with assays such as Western blotting for GTF2H5 depletion, UV sensitivity and comet assays, RNA-seq and RT-qPCR for NER gene expression, flow cytometry for apoptosis, and immunofluorescence for TFIIH localization. In drug discovery, these cells enable screening of NER-targeted compounds and DNA-damaging agent sensitizers. For further technical inquiries or custom orders, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)